6505--Tacrolimus Capsules
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 36E79726R0033
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue RFP 36E79726R0033 for Tacrolimus Capsules on or about August 31, 2026, with a tentative closing date of September 15, 2026. This is an unrestricted, single-award procurement in commercial item format under FAR Part 12.
The VA will procure Tacrolimus Capsules for the Department of Veterans Affairs (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Estimated annual requirements total 199,899 bottles across three dosage strengths: 51,904 bottles of 0.5mg capsules, 142,788 bottles of 1mg capsules, and 5,207 bottles of 5mg capsules, all in 100-bottle package sizes. The contract period is one year plus four pre-priced one-year option periods.
Distribution will occur through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. The successful contractor must provide an uninterrupted source of supply and supply the drug under an exact label name with a unique NDC number specific to the offeror; the contractor's label shall be the only label on the product. Offerors must state the exact name by which the drug will be supplied on the label.
All solicitation documents will be issued and available electronically at SAM.gov; no paper copies will be distributed. Contact VA National Acquisition Center Contract Specialist Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980 with questions. NAICS 325412.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0033 for an unrestricted procurement for Tacrolimus Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.
Solicitation #36E79726R0033 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 31, 2026, with a tentative closing date of September 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Bottles)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
TACROLIMUS 0.5MG CAP
100
51,904
2
TACROLIMUS 1MG CAP
100
142,788
3
TACROLIMUS 5MG CAP
100
5,207
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0033_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Tacrolimus Capsules | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity